We are live on
!
Find out more
MCO
MAK Capital One Portfolio holdings
AUM
$714M
1-Year Est. Return
68.07%
This Fund
S&P 500
This Quarter
Est. Return
-9.13%
1 Year Est. Return
+68.07%
3 Year Est. Return
+199.63%
5 Year Est. Return
+307.07%
10 Year Est. Return
+2,541.72%
AUM
$306M
AUM Growth
-$280M
(-48%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-64.81%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
3
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$5.8M |
| 2 |
Yatra Online
YTRA
|
+$643K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Champion Homes
SKY
|
+$201M |
| 2 |
PTC Therapeutics
PTCT
|
+$2.99M |
| 3 |
MXWL
Maxwell Technologies Inc
MXWL
|
+$103K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 62.74% |
| 2 | Technology | 28.18% |
| 3 | Healthcare | 5.75% |
| 4 | Industrials | 3.33% |
Similar funds
SAM
OL
LWM
HA
TC
FCFC
ADIC
ZAM
MAK Capital One's Q3 2018 Portfolio in Review
As of Q3 2018, MAK Capital One held 6 positions worth $306M, down 48% from $586M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MAK Capital One withdrew a net $198M in Q3 2018, reducing 3 holdings. Its largest reduction was Champion Homes, cutting an estimated $201M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 63% of assets, down from 82% a quarter earlier, followed by Technology and Healthcare.
Against the trend, MAK Capital One opened a new position in Achillion Pharmaceuticals worth $7.16M.
- MAK Capital One's largest Q3 2018 buy was Achillion Pharmaceuticals: 1,946,107 shares worth $7.16M.
- MAK Capital One's biggest Q3 2018 reduction was Champion Homes, cutting an estimated $201M.
- MAK Capital One's ten largest holdings make up 100% of its $306M portfolio in Q3 2018.
- MAK Capital One opened 2 new positions and closed 0 in Q3 2018.
- MAK Capital One's portfolio value fell 48% quarter-over-quarter to $306M.
Based on MAK Capital One's 13F filing for Q3 2018, filed 14 Nov 2018.